Department of Public Health, Erasmus MC University Medical Center, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands.
Fundación para el Fomento en Asturias de la Investigación Científica Aplicada y la Tecnología (FICYT), Cabo Noval St, 11, 1ºC, 33007 Oviedo-Asturias, Spain.
Int J Environ Res Public Health. 2019 May 28;16(11):1883. doi: 10.3390/ijerph16111883.
: The Chronic Disease Self-Management Programme (CDSMP) intervention is an evidence-based program that aims to encourage citizens with a chronic condition, as well as their caregivers, to better manage and maintain their own health. CDSMP intervention is expected to achieve greater health gains in citizens with a low socioeconomic position (SEP), because citizens with a low SEP have fewer opportunities to adhere to a healthy lifestyle, more adverse chronic conditions and a poorer overall health compared to citizens with a higher SEP. In the EFFICHRONIC project, CDSMP intervention is offered specifically to adults with a chronic condition and a low SEP, as well as to their caregivers (target population). : The objective of our study is to evaluate the benefits of offering CDSMP intervention to the target population. : A total of 2500 participants (500 in each study site) are recruited to receive the CDSMP intervention. The evaluation study has a pre-post design. Data will be collected from participants before the start of the intervention (baseline) and six months later (follow up). Benefits of the intervention include self-management in healthy lifestyle, depression, sleep and fatigue, medication adherence and health-related quality of life, health literacy, communication with healthcare professionals, prevalence of perceived medical errors and satisfaction with the intervention. The study further includes a preliminary cost-effectiveness analysis with a time horizon of six months. : The EFFICHRONIC project will measure the effects of the CDSMP intervention on the target population and the societal cost savings in five European settings.
慢性病自我管理计划(CDSMP)干预措施是一个循证项目,旨在鼓励患有慢性病的公民及其照顾者更好地管理和维护自己的健康。预计 CDSMP 干预措施将使社会经济地位较低(SEP)的公民获得更大的健康收益,因为与社会经济地位较高的公民相比,SEP 较低的公民获得健康生活方式的机会较少,患有更多不利的慢性病,整体健康状况较差。在 EFFICHRONIC 项目中,CDSMP 干预措施专门提供给患有慢性病和社会经济地位较低的成年人及其照顾者(目标人群)。
我们的研究目的是评估向目标人群提供 CDSMP 干预措施的益处。
共有 2500 名参与者(每个研究地点 500 名)被招募接受 CDSMP 干预。评估研究采用前后设计。参与者在干预开始前(基线)和六个月后(随访)收集数据。干预的益处包括健康生活方式、抑郁、睡眠和疲劳、药物依从性和健康相关生活质量、健康素养、与医疗保健专业人员的沟通、感知医疗错误的发生率和对干预的满意度的自我管理。该研究还包括为期六个月的初步成本效益分析。
EFFICHRONIC 项目将在五个欧洲环境中测量 CDSMP 干预措施对目标人群的影响和对社会的成本节约。